2001
DOI: 10.1006/bbrc.2001.5312
|View full text |Cite
|
Sign up to set email alerts
|

Upregulation of Vascular NAD(P)H Oxidase Subunit gp91phox and Impairment of the Nitric Oxide Signal Transduction Pathway in Hypertension

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
33
0

Year Published

2004
2004
2016
2016

Publication Types

Select...
6
2
2

Relationship

0
10

Authors

Journals

citations
Cited by 65 publications
(35 citation statements)
references
References 49 publications
(43 reference statements)
2
33
0
Order By: Relevance
“…A key problem in this field is the lack of specific inhibitors and antibodies. Thus, although previous studies have shown increased NOX mRNA expression, 25,26 as well as increased NOX2 protein levels, 27 data on the aortic protein levels of all rodent vascular NOX isoforms in hypertensive animal models are missing. In addition, because of the lack of specific NADPH oxidase inhibitors, reliable pharmacological evidence that NADPH oxidases indeed play a functional role in this setting has not yet been possible.…”
Section: Discussionmentioning
confidence: 97%
“…A key problem in this field is the lack of specific inhibitors and antibodies. Thus, although previous studies have shown increased NOX mRNA expression, 25,26 as well as increased NOX2 protein levels, 27 data on the aortic protein levels of all rodent vascular NOX isoforms in hypertensive animal models are missing. In addition, because of the lack of specific NADPH oxidase inhibitors, reliable pharmacological evidence that NADPH oxidases indeed play a functional role in this setting has not yet been possible.…”
Section: Discussionmentioning
confidence: 97%
“…54 In addition, increased Nox activity has been observed in different animal models of hypertension including ATII infusion, 14,55,56 deoxycorticosterone acetate (DOCA)-salt hypertension, 57 renovascular hypertension 58 and in spontaneously hypertensive rats. 59 Whether ROS derived from the Nox activation has a causal role in the development of hypertension was investigated by several animal studies using specific knockdown of Nox subunits. A major ROS source in response to ATII is Nox1 in the vascular smooth muscle layer.…”
Section: Ros Sources In Hypertension Nadph Oxidasesmentioning
confidence: 99%
“…In contrast, gp91 phox expression was knocked down by antisense oligos in resistance arteries from humans, and this led to abrogation of ROS production, whereas Nox1 expression was not detected here (327). The role of gp91 phox (Nox2) in hypertension was described by Morawietz et al (219), who showed that tenfold-elevated mRNA levels in the aorta were associated with threefold elevated levels of O 2 и-anion production in stroke-prone SHRs (SHR15) (219). In SHR15 rats, a decreased response to ACh, NO-donor (S-nitroso-N-acetyld, l-penicillamine), and organic nitrate (glyceryl trinitrate) was found, compared with an age-matched wild-type control, Wistar rats (WIS15).…”
Section: Nistala Et Al 2062mentioning
confidence: 99%